These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 16507353)

  • 1. Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.
    Jumpsen JA; Brown NE; Thomson AB; Paul Man SF; Goh YK; Ma D; Clandinin MT
    J Cyst Fibros; 2006 May; 5(2):77-84. PubMed ID: 16507353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study.
    Lloyd-Still JD; Powers CA; Hoffman DR; Boyd-Trull K; Lester LA; Benisek DC; Arterburn LM
    Nutrition; 2006 Jan; 22(1):36-46. PubMed ID: 16226012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients.
    Van Biervliet S; Vanbillemont G; Van Biervliet JP; Declercq D; Robberecht E; Christophe A
    Ann Nutr Metab; 2007; 51(6):541-9. PubMed ID: 18227622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients.
    Van Biervliet S; Devos M; Delhaye T; Van Biervliet JP; Robberecht E; Christophe A
    Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):109-15. PubMed ID: 18276127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis.
    Al-Turkmani MR; Freedman SD; Laposata M
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):309-18. PubMed ID: 18036797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cystic fibrosis with abnormalities in fatty acid metabolism.
    Freedman SD; Blanco PG; Zaman MM; Shea JC; Ollero M; Hopper IK; Weed DA; Gelrud A; Regan MM; Laposata M; Alvarez JG; O'Sullivan BP
    N Engl J Med; 2004 Feb; 350(6):560-9. PubMed ID: 14762183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis.
    Strandvik B; Gronowitz E; Enlund F; Martinsson T; Wahlström J
    J Pediatr; 2001 Nov; 139(5):650-5. PubMed ID: 11713441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis.
    Olveira G; Olveira C; Acosta E; Espíldora F; Garrido-Sánchez L; García-Escobar E; Rojo-Martínez G; Gonzalo M; Soriguer F
    Arch Bronconeumol; 2010 Feb; 46(2):70-7. PubMed ID: 20045240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition.
    Makrides M; Neumann MA; Gibson RA
    Eur J Clin Nutr; 1996 Jun; 50(6):352-7. PubMed ID: 8793415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of supplementation with docosahexaenoic and arachidonic acid derived from single cell oils on plasma and erythrocyte fatty acids of pregnant women in the second trimester.
    Otto SJ; van Houwelingen AC; Hornstra G
    Prostaglandins Leukot Essent Fatty Acids; 2000 Nov; 63(5):323-8. PubMed ID: 11090260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis.
    Coste TC; Armand M; Lebacq J; Lebecque P; Wallemacq P; Leal T
    Clin Biochem; 2007 May; 40(8):511-20. PubMed ID: 17316592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acids composition of plasma phospholipids and triglycerides in children with cystic fibrosis. The effect of dietary supplementation with an olive and soybean oils mixture.
    Caramia G; Cocchi M; Gagliardini R; Malavolta M; Mozzon M; Frega NG
    Pediatr Med Chir; 2003; 25(1):42-9. PubMed ID: 12920976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary docosahexaenoic acid but not arachidonic acid influences central nervous system fatty acid status in baboon neonates.
    Hsieh AT; Brenna JT
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):105-10. PubMed ID: 19524425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docosahexaenoic acid-enriched egg phospholipids supplementation induces accretion of arachidonic acid in rat blood lipids.
    Gleize B; Payet M; Esmail MH; Pieroni G; Coste TC
    Cell Mol Biol (Noisy-le-grand); 2004 Nov; 50(7):861-7. PubMed ID: 15672471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docosahexaenoic acid-enriched egg consumption induces accretion of arachidonic acid in erythrocytes of elderly patients.
    Payet M; Esmail MH; Polichetti E; Le Brun G; Adjemout L; Donnarel G; Portugal H; Pieroni G
    Br J Nutr; 2004 May; 91(5):789-96. PubMed ID: 15137931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated prostaglandin E metabolites and abnormal plasma fatty acids at baseline in pediatric cystic fibrosis patients: a pilot study.
    O'Connor MG; Thomsen K; Brown RF; Laposata M; Seegmiller A
    Prostaglandins Leukot Essent Fatty Acids; 2016 Oct; 113():46-49. PubMed ID: 27720040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acids platelets and oxidative markers following intravenous n-3 fatty acids administration in cystic fibrosis: An open pilot observational study.
    Durieu I; Vericel E; Guichardant D; Roth H; Steghens JP; Drai J; Josserand RN; Fontaine E; Lagarde M; Bellon G
    J Cyst Fibros; 2007 Sep; 6(5):320-6. PubMed ID: 17257908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral supplementation with a high-fat, high-energy product improves nutritional status and alters serum lipids in patients with cystic fibrosis.
    Rettammel AL; Marcus MS; Farrell PM; Sondel SA; Koscik RE; Mischler EH
    J Am Diet Assoc; 1995 Apr; 95(4):454-9. PubMed ID: 7699188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events.
    Bijvelds MJ; Bronsveld I; Havinga R; Sinaasappel M; de Jonge HR; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G646-53. PubMed ID: 15528257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
    Dorlöchter L; Aksnes L; Fluge G
    Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.